Finalized EMA Guideline on Cancer Drug Development Pushes Elderly Patient Studies

Drug Industry Daily
A A
The European Medicines Agency (EMA) has finalized a revised guideline on anticancer drug development, placing additional emphasis on the inclusion of elderly patients in clinical trials.

To View This Article:

Login

Subscribe To Drug Industry Daily